Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionOral, small molecule delta isoform selective phosphoinositide 3-kinase (PI3K) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) delta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase 0
Standard IndicationRhinitis
Indication DetailsTreat allergic rhinitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today